The increasing need for convenient diagnostic and accurate therapeutic tools is driving innovation in smart pills. While certain smart pill applications, such as imaging and sensing, have been successfully commercialized, others like drug delivery and surgery are yet to be proven clinically.
Advanced Accelerator Applications, a fast growing international specialist in Molecular Nuclear Medicine (MNM), announced today that it has entered into an agreement to acquire 100% of the shares of Imaging Equipment Ltd, a privately-held UK distributor of nuclear medicine products and technologies, in newly issued AAA shares.
Low-molecular-weight heparin is commonly used in surgeries to prevent dangerous blood clots. But when patients experience the other extreme - uncontrolled bleeding - in response to low-molecular-weight heparin, there is no antidote.
Shingles is a painful viral infection that affects almost one million people worldwide and 30 percent of Americans every year.
Enough women experience reproductive coercion - male behavior to control contraception and pregnancy outcomes - that a research team now recommends health care providers address the subjects with their patients and tailor family planning discussions and recommendations accordingly.
We have tended to associate welfare technology with support for the elderly. Now researchers are looking at whether technology such as digital calendars and smartwatches can also provide support for children with autism and ADHD.
Noninvasive imaging of carotid artery plaque with MRI can accurately predict future cardiovascular events like strokes and heart attacks in people without a history of cardiovascular disease, according to a new study published online in the journal Radiology.
A selection of health policy stories from Florida, California, the District of Columbia, Pennsylvania and Wisconsin.
For those coping with Crohn's disease, a new research report published in the Journal of Leukocyte Biology offers hope for the development of new and more effective drugs. In the report, scientists show for the first time, precisely what type of immune cells are involved in driving the inflammation process in the disease.
Thanks to a new partnership, families spending time at the Sanford Children's Hospital in Sioux Falls can easily take a trip to the San Diego Zoo through a new television channel.
Researchers found initial confirmation that a novel scaffold protein previously unassociated with the mu opioid receptor (MOR) regulates MOR-induced signaling activation.
Six weeks ago 67-year old John Galbreath welcomed death, rather than live one more day. Intense pain in his chest had left him nearly bedridden for four months. Galbreath had a condition called jackhammer esophagus, which made him feel like the name suggests—like a jackhammer was going off in his chest.
Urinary urgency is the most bothersome lower urinary tract symptom at the population level, whereas urgency incontinence causes the most bother to individuals, a large European survey reveals.
A 1-month programme of physical therapy results in significant improvements in quality of life among women with urinary incontinence, a clinical trial has found.
Behaviours associated with controlling sleep and managing the negative effects of insomnia are independently associated with disturbed sleep in patients with anxiety or depressive disorders, US research shows.
Swedish researchers studying Streptococcus pneumoniae have discovered “hypervirulent” mutant forms of the bacteria that are selected for because they are more resistant to clearance by macrophages.
Calculating blood pressure load does not increase physicians’ ability to predict a patient’s risk of cardiovascular events, research shows.
The incidence of autism spectrum disorders has increased sharply since it was first described 60 years ago. Today, ASD affects more than 1% of all children in the U.S. and about half of them develop a life-long disability.
Dendreon Corporation today announced that it plans to make PROVENGE (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
Wilson Medical Center and Duke LifePoint Healthcare have completed the formation of their new joint venture following approval by the Attorney General of North Carolina. The organizations now officially share ownership and operation of Wilson Medical Center.